We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

69 hedge funds and large institutions have $143M invested in Voyager Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

917% more call options, than puts

Call options by funds: $4.47M | Put options by funds: $440K

21% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 19

12% more capital invested

Capital invested by funds: $127M → $143M (+$15.7M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.16% less ownership

Funds ownership: 62.61% → 62.45% (-0.16%)

12% less funds holding

Funds holding: 78 → 69 (-9)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
69
Holders Change
-9
Holders Change %
-11.54%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
23
Reduced
19
Closed
15
Calls
$4.47M
Puts
$440K
Net Calls
+$4.03M
Net Calls Change
+$221K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$5.33M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.85M
3
Morgan Stanley
Morgan Stanley
New York
+$1.41M
4
Marshall Wace
Marshall Wace
United Kingdom
+$1.21M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.15M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$6.16M
2
Millennium Management
Millennium Management
New York
-$3.24M
3
BI
BVF Inc
California
-$827K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$596K
5
E
Ergoteles
New York
-$344K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$526K – – –
HIM
27
Hillsdale Investment Management
Ontario, Canada
$521K +$437K +68,300 +347%
Goldman Sachs
28
Goldman Sachs
New York
$512K -$150K -23,487 -21%
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$465K – – –
Northern Trust
30
Northern Trust
Illinois
$456K +$14K +2,192 +3%
GGHC
31
Gilder Gagnon Howe & Co
New York
$442K +$111K +17,394 +30%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$414K -$640 -100 -0.1%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$401K -$180K -28,177 -29%
Deutsche Bank
34
Deutsche Bank
Germany
$326K – – –
TD Asset Management
35
TD Asset Management
Ontario, Canada
$326K – – –
RJFSA
36
Raymond James Financial Services Advisors
Florida
$224K +$25.2K +3,933 +12%
CSS
37
Cubist Systematic Strategies
Connecticut
$211K -$172K -26,851 -43%
LP
38
LMR Partners
United Kingdom
$196K – – –
Two Sigma Advisers
39
Two Sigma Advisers
New York
$191K +$10.2K +1,600 +5%
B
40
Bailard
California
$171K +$185K +28,900 New
XT
41
XTX Topco
Cayman Islands
$170K +$20.4K +3,193 +13%
Blackstone Inc
42
Blackstone Inc
New York
$161K – – –
OQS
43
Occudo Quantitative Strategies
Florida
$157K -$61.2K -9,559 -26%
JF
44
Jump Financial
Illinois
$154K -$62.6K -9,778 -27%
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$149K +$41.9K +6,544 +35%
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$144K – – –
AWM
47
Aevitas Wealth Management
Massachusetts
$130K – – –
SSA
48
Schonfeld Strategic Advisors
New York
$117K -$44.8K -7,000 -26%
Franklin Resources
49
Franklin Resources
California
$105K +$1.2K +188 +1%
Assenagon Asset Management
50
Assenagon Asset Management
Luxembourg
$96K -$22.5K -3,517 -18%
1
2
3 4

VYGR Hedge Fund Activity: Q3 2022 in Review

69 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2022, worth a combined $143M — up 12% from $127M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of VYGR and 6 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 23 added.

The largest buyer was Armistice Capital, adding an estimated $5.33M. The largest seller was TRV GP III, cutting an estimated $6.16M.

  • 69 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2022, down from 78 in Q2 2022.
  • Funds reported $143M of Voyager Therapeutics stock for Q3 2022, up 12% quarter-over-quarter.
  • 6 funds opened new Voyager Therapeutics positions in Q3 2022 and 15 closed out, a net change of -9 holders.
  • The largest Voyager Therapeutics buyer in Q3 2022 was Armistice Capital, an estimated $5.33M added.
  • The largest Voyager Therapeutics seller in Q3 2022 was TRV GP III, an estimated $6.16M sold.

Based on aggregated 13F filings for Q3 2022.